Zelira Therapeutics Limited (ZLD.AX)
AUD 0.62
(1.64%)
AUD 0.62
(1.64%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 94.95 Thousand | 301.12 Thousand | 1.54 Million | 663.31 Thousand | - | 769.03 Thousand |
| Cost of Revenue | 84.66 Thousand | 3.51 Million | 7.25 Million | 702.47 Thousand | 275.05 Thousand | - |
| Gross Profit | 10.28 Thousand | -3.21 Million | -5.71 Million | -39.16 Thousand | -275.05 Thousand | 769.03 Thousand |
| Operating Expenses | 5.94 Million | 4.19 Million | 7.69 Million | 9.61 Million | 7.56 Million | 4.22 Million |
| Selling, General and Administrative Expenses | 1.33 Million | 2.59 Million | 6.3 Million | 7.53 Million | 3.87 Million | 1.89 Million |
| Research and Development Expenses | 2.81 Million | 1.33 Million | 1.39 Million | 2.08 Million | 3.69 Million | 2.32 Million |
| Other Expenses | 1.8 Million | -266.52 Thousand | 1.27 Million | 1.48 Million | 925.49 Thousand | 580.44 Thousand |
| Cost and Expenses | 6.26 Million | 7.71 Million | 14.95 Million | 10.31 Million | 7.83 Million | 4.22 Million |
| Operating Income | -5.93 Million | -7.41 Million | -13.41 Million | -9.65 Million | -7.83 Million | -4.22 Million |
| Interest Expense | 739.27 Thousand | 76.66 Thousand | 53.84 Thousand | 42.62 Thousand | 12.34 Thousand | - |
| Income Tax Expense | -919.73 Thousand | -1.14 Million | -1.29 Million | -1.37 Million | -981.77 Thousand | -769.03 Thousand |
| Earnings before Tax | -37.65 Million | -7.41 Million | -13.7 Million | -9.92 Million | -7.99 Million | -4.33 Million |
| Net Income | -36.56 Million | -5.57 Million | -11.94 Million | -8.54 Million | -7.01 Million | -3.56 Million |
| Earnings Per Share Basic | -3.22 | -0.55 | -1.49 | -1.29 | -1.45 | -0.83 |
| Earnings Per Share Diluted | -3.22 | -0.55 | -1.49 | -1.29 | -1.45 | -0.83 |
| Weighted Average Shares Outstanding | 11.34 Million | 10.06 Million | 8.04 Million | 6.63 Million | 4.84 Million | 4.31 Million |
| Weighted Average Shares Outstanding (Diluted) | 11.34 Million | 10.06 Million | 8.04 Million | 6.63 Million | 4.84 Million | 4.31 Million |
| Gross Margin | 0.11 | -10.68 | -3.71 | -0.06 | - | 1.00 |
| EBIT Margin | -383.79 | -22.81 | -8.33 | -13.84 | - | -5.50 |
| Profit Margin | -385.13 | -18.51 | -7.75 | -12.89 | - | -4.64 |
| EBITDA | -36.44 Million | -6.86 Million | -12.82 Million | -9.17 Million | -7.7 Million | -251.28 Thousand |
| Earnings Before Tax Margin | -62.54 | -24.62 | -8.71 | -14.55 | - | -5.50 |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 94.95 Thousand | 40.22 Thousand | 54.72 Thousand | 224.17 Thousand | 301.12 Thousand | 76.94 Thousand |
| Cost of Revenue | 1.48 Million | 323.3 Thousand | 1.15 Million | 1.4 Million | 3.51 Million | 2.1 Million |
| Gross Profit | -1.38 Million | -283.08 Thousand | -1.1 Million | -1.18 Million | -3.21 Million | -2.03 Million |
| Operating Expenses | 4.78 Million | 2.55 Million | 2.23 Million | 2.73 Million | 4.19 Million | 1.46 Million |
| Selling, General and Administrative Expenses | - | 820.03 Thousand | 910.37 Thousand | 1.92 Million | - | 666.02 Thousand |
| Research and Development Expenses | - | 1.56 Million | 1.24 Million | 787.99 Thousand | - | 548.43 Thousand |
| Other Expenses | -244.22 Thousand | -165.27 Thousand | -78.95 Thousand | -14.9 Thousand | -266.52 Thousand | -251.62 Thousand |
| Cost and Expenses | 6.26 Million | 2.87 Million | 3.39 Million | 4.13 Million | 7.71 Million | 3.57 Million |
| Operating Income | -6.17 Million | -2.83 Million | -3.33 Million | -3.91 Million | -7.41 Million | -3.49 Million |
| Interest Expense | 739.27 Thousand | 528.13 Thousand | 211.13 Thousand | 44.51 Thousand | 76.66 Thousand | 32.14 Thousand |
| Income Tax Expense | -919.73 Thousand | -919.73 Thousand | -187.77 Thousand | -1.14 Million | -1.14 Million | -387.42 Thousand |
| Earnings before Tax | -37.65 Million | -3.33 Million | -34.32 Million | -3.74 Million | -7.41 Million | -3.66 Million |
| Net Income | -36.56 Million | -2.43 Million | -34.13 Million | -2.29 Million | -5.57 Million | -3.27 Million |
| Earnings Per Share Basic | - | -0.21 | -3.01 | -0.21 | - | -0.34 |
| Earnings Per Share Diluted | - | -0.21 | -3.01 | -0.21 | - | -0.34 |
| Weighted Average Shares Outstanding | 11.34 Million | 11.34 Million | 11.34 Million | 10.86 Million | 10.06 Million | 9.57 Million |
| Weighted Average Shares Outstanding (Diluted) | 11.34 Million | 11.34 Million | 11.34 Million | 10.86 Million | 10.06 Million | 9.57 Million |
| Gross Margin | -14.62 | -7.04 | -20.19 | -5.28 | -10.68 | -26.42 |
| EBIT Margin | - | -65.44 | -55.95 | -16.25 | - | -41.90 |
| Profit Margin | -385.13 | -60.51 | -623.78 | -10.24 | -18.51 | -42.59 |
| EBITDA | - | -2.63 Million | -3.06 Million | -3.64 Million | - | -3.22 Million |
| Earnings Before Tax Margin | -65.01 | -70.47 | -61.00 | -17.46 | -24.62 | -45.47 |
MTRN
3673
WHGRF
002965
WPRT
DC7